Origin Sciences

Orbit Genomics

This company develops AI-powered genomic tests for healthcare providers and patients to diagnose lung cancer and evaluate risks for chronic diseases.

Cernostics

This company develops image analysis tests for tissue biopsies to predict cancer risk in patients with Barrett's esophagus for gastroenterologists and clinicians.

Epigenomics

This molecular diagnostics company develops blood-based liquid biopsy tests for the early detection and screening of cancer for healthcare providers and clinical laboratories.

BillionToOne

This company develops molecular diagnostic tests for prenatal screening and oncology care to help clinicians and patients identify genetic conditions and monitor cancer.

Convergent Genomics

This company develops non-invasive urine-based genomic tests to detect and monitor bladder cancer for clinicians and their patients.

ORISDX

This company develops non-invasive salivary diagnostic tests for early oral cancer detection, serving dentists, oncologists and primary care providers.

Genomic Vision

This company develops molecular combing technology and DNA analysis tools for researchers and clinicians in diagnostic and drug discovery sectors.

Foresight Diagnostics

This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.